1. The plaintiff's claim is dismissed.

2. The costs of lawsuit shall be borne by the Plaintiff.

1. Basic facts

(a) The name of the Defendant’s patented invention of this case (hereinafter “instant patented invention”): The date of filing of the treatment method for the treatment of the Ansan building using the clurine receptors / the filing date/ the filing date/ the application number / the registration date/ the registration number of the patent: the date of February 6, 1999/ February 6, 1997/ No. 10-199-707113//37843/3 of March 19, 203: the Defendant (the patent registration registration of the patent from the Insurmathy Republic of Strad on April 16, 2015)

B. / Application number for the registration of extension of the patent term extension (hereinafter “instant application for registration of extension”) of the instant patent (hereinafter “instant application for registration”): The scope of claims subject to extension under paragraphs (1) through (2), (4) through (5), (14) through (15), (22) through (23), (26) through (31), and (34 (hereinafter “instant application for registration of extension”) on March 29, 2012: The extended period of 171 days registration (hereinafter “decision on the registration of extension”):

C. After the establishment of a patent right for the patented invention of this case was registered on March 29, 201, Korea Human Content Co., Ltd. (hereinafter “Korea Human Content Co., Ltd.”) examined the safety and effectiveness of the examination of the safety and effectiveness of the imported pharmaceutical products (hereinafter “NE examination”) upon filing an application for import approval of the patented invention of this case on March 29, 201.

The criteria for criteria and testing methods for drugs (hereinafter referred to as "visual examination") and testing methods shall be conducted for the manufacture and quality control of the items of drugs (e.g., sexuality, netity, content, quantitative method, special test (fire extinguishing force, micro-organism test), etc.